Potential and Existing Impact of Vaccines on Disease Epidemiology

The Vaccine Book

Volumn , Issue , 2003, Pages 37-50

  Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903331008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012107258-2/50005-6     Document Type: Chapter

References (35)

1. Allwright S.P.A. Elimination or reduction of diseases?. Opportunities for Health Service Action in Europe 1998, 5-7. Oxford Medical Publications, Oxford, UK. E.J. Silman, S.P.A. Allwright (Eds.).
2. Miller E. Can congenital rubella be eliminated?. Public Health Virology 1986, 36-49. Public Health Laboratory Service, London. P. Mortimer (Ed.).
3. De Serres G., Gay N., Farrington C.P. Epidemiology of transmissible diseases after elimination. Am. J. Epidemiol. 2000, 151:1039-1048.
4. Ramsay M. A strategic framework for the elimination of measles in the European region 1999, World Health Organization Regional Office for Europe, Copenhagen.
5. Hersch B.S., Tambini G., Nogueira A.C., Carrasco P., de Quadros C. Review of regional measles surveillance data in the Americas 1996-99. Lancet 2000, 355:1943-1948.
6. Cutts F.T., Henao-Restrepo A.M., Olive J.M. Measles elimination: Progress and challenges. Naccine 1999, S47-S52.
7. Gay N.J. Eliminating measles-No quick fix. Bull. WHO 2000, 78:949.
8. Taylor C., Cutts F., Taylor M. Ethical dilemmas in current planning for polio eradication. Am. J. Public Health 1997, 87:922-925.
9. Cutts F.T., Steinglass R. Should measles be eradicated?. Br. Med. J. 1998, 316:765-767.
10. Begg N., Miller E. Role of epidemiology in vaccine policy. Vaccine 1990, 8:180-189.
11. Osborne K., Gay N., Hesketh L., Morgan-Capner P., Miller E. Ten years of serological surveillance in England and Wales: Methods, results, implications and action. Int. J. Epidemiol. 2000, 29:362-368.
12. http://www.phls.org.uk/publications/CDR%20Weekly/pages/immunisation.html#MMR27-39.
13. Nokes D.J., Anderson R.M. The use of mathematical models in the epidemiological study of infectious diseases and the design of vaccination programmes. Epidemiol. Infect. 1988, 101:1-20.
14. Fine P.E.M., Clarkson J.A. Measles in England and Wales II. The impact of the measles vaccination programme on the distribution of immunity in the population. Int. J. Epidemiol. 1982, II:15-25.
15. Gay N., Hesketh L.M., Morgan-Capner P., Miller E. Interpreting serological surveillance data for measles using mathematical models: Implications for vaccine strategy. Epidemiol. Infect. 1995, 115:139-156.
16. Babad H.R., Nokes D.J., Gay N.J., Miller E., Morgan-Capner P., Anderson R.M. Predicting the impact of measles vaccination in England and Wales: Model validation and analysis of policy options. Epidemiol. Infect. 1995, 114:319-344.
17. Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. IMA J. Math Appl. Med. Biol. 1998, 1:169-191.
18. Anderson R.M., May R.M. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University Press, Oxford, UK. 2nd ed.
19. Grenfell B.T., Anderson R.M. The estimation of age-related rates of infection from case notifications and serological data. J. Hygiene (Cambridge) 1995, 95:419-436.
20. Farrington C.P. Modelling forces of infection for measles, mumps and rubella. Stat. Medicine 1990, 9:953-967.
21. Edmunds W.J., van de Heijden O.G., Eerola M., Gay N.J. Modelling rubella in Europe. Epidemiol Infect. 2000, 125:617-634.
22. Evans A.S. The eradication of communicable diseases: Myth or reality?. Am. J. Epidemiol. 1985, 122:199-207.
23. Atkinson W.L., Orenstein W.A. The resurgence of measles in the United States, 1989-90. Annu. Rev. Med. 1992, 43:451-463.
24. de Quadros C.A., Hersh B.S., Nogueira A.C., Carasco P.A., da Silveira C.M. Measles eradication: Experience in the Americas. Bull. WHO 1998, 76(Suppl 2):42-52.
25. Forrest J.M., Burgess M.A., Heath T.C., McIntyre P.B. Measles control in Australia. Communicable Dis. Intell. 1998, 22:33-36.
26. Knox E.G. Strategy for rubella vaccination. Int. J. Epidemiol. 1980, 9:13-23.
27. Panagiotopoulos T., Antoniadou I., Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: Retrospective survey and systematic review. Br. Med. J. 1999, 319:1462-1467.
28. Edmunds W.J., Gay N.J., Kretzschmar M., Pebody R.G., Wachmann H. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling. Epidemiol. Infect. 2000, 125:635-650.
29. Anderson R.M., Grenfell B.T. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J. Hygiene Cambridge 1986, 96:305-333.
30. World Health Organization Rubella vaccines: WHO position paper. Weekly Epidemiol. Record 2000, 75:161-172.
31. Garnett G.P., Grenfell B.T. The epidemiology of varicella-zoster virus infections: A mathematical model. Epidemiol. Infect. 1992, 108:495-511.
32. Halloran M.E., Cochi S.L., Lieu T.A., Wharton M., Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am. J. Epidemiol. 1994, 140:81-104.
33. Garnett G.P., Ferguson N.M. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev. Med. Virol. 1996, 6:151-161.
34. Brisson M., Edmunds W.J., Gay N.J., Law B., De Serres G. Modelling the impact of immunisation on the epidemiology of varicella zoster virus. Epidemiol. Infect. 2000, 125:651-669.
35. Schuette M.C., Hethcote H.W. Modeling the effects of varicalla vaccination programs on the incidence of chickenpox and shingles. Bull. Math Biol. 1999, 61.